Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms

被引:0
作者
Xie, Zhuoer [1 ]
Chen, Evan C. C. [2 ,3 ]
Mendez, Lourdes M. [4 ,5 ]
Komrokji, Rami [1 ]
Zeidan, Amer M. [4 ,5 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Adult Leukemia Program, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Yale Univ, Yale Canc Ctr, Dept Internal Med, Sect Hematol,Sch Med, 37 Coll St,First Floor, New Haven, CT 06510 USA
[5] Yale Univ, Smilow Canc Hosp, Sch Med, 37 Coll St,First Floor, New Haven, CT 06510 USA
关键词
AML; CCUS; CHIP; CMUS; MDS; SOMATIC MUTATIONS; RISK; COMMON; CHIP; PREVALENCE; DYNAMICS; CELLS; MDS;
D O I
10.1097/PPO.0000000000000656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clonal hematopoiesis (CH) confers a high risk of aging-related diseases and hematologic malignancy. There are still significant knowledge gaps in identifying high-risk patients with CH and managing such patients. In this review, we focus on 3 areas: (1) the natural history of CH; (2) the risks of progression of CH, including CH of indeterminate potential, clonal cytopenia of undetermined significance, and therapy-related CH, to myeloid malignancy; and (3) the challenges and unmet needs of CH management and research.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 71 条
[11]  
Bouzid H., 2021, MEDRXIV, DOI [10.1101/2021.12.10.21267552, DOI 10.1101/2021.12.10.21267552]
[12]   DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions [J].
Buscarlet, Manuel ;
Provost, Sylvie ;
Zada, Yassamin Feroz ;
Barhdadi, Amina ;
Bourgoin, Vincent ;
Lepine, Guylaine ;
Mollica, Luigina ;
Szuber, Natasha ;
Dube, Marie-Pierre ;
Busque, Lambert .
BLOOD, 2017, 130 (06) :753-762
[13]   The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis [J].
Cargo, Catherine ;
Cullen, Matthew ;
Taylor, Jan ;
Short, Mike ;
Glover, Paul ;
Van Hoppe, Suzan ;
Smith, Alex ;
Evans, Paul ;
Crouch, Simon .
BLOOD, 2019, 133 (12) :1325-1334
[14]   Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression [J].
Cargo, Catherine A. ;
Rowbotham, Nicola ;
Evans, Paul A. ;
Barrens, Sharon L. ;
Bowen, David T. ;
Crouch, Simon ;
Jack, Andrew S. .
BLOOD, 2015, 126 (21) :2362-2365
[15]   Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation [J].
Chitre, Sneha ;
Stoelzel, Friedrich ;
Cuthill, Kirsty ;
Streetly, Mathew ;
Graham, Charlotte ;
Dill, Claudia ;
Mohamedali, Azim ;
Smith, Alexander ;
Schetelig, Johannes ;
Altmann, Heidi ;
Bornhaeuser, Martin ;
Mufti, Ghulam J. .
LEUKEMIA, 2018, 32 (09) :2020-2024
[16]   Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes [J].
Coombs, Catherine C. ;
Zehir, Ahmet ;
Devlin, Sean M. ;
Kishtagari, Ashwin ;
Syed, Aijazuddin ;
Jonsson, Philip ;
Hyman, David M. ;
Solit, David B. ;
Robson, Mark E. ;
Baselga, Jose ;
Arcila, Maria E. ;
Ladanyi, Marc ;
Tallman, Martin S. ;
Levine, Ross L. ;
Berger, Michael F. .
CELL STEM CELL, 2017, 21 (03) :374-+
[17]   Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease [J].
Dawoud, Ahmed A. Z. ;
Gilbert, Rodney D. ;
Tapper, William J. ;
Cross, Nicholas C. P. .
LEUKEMIA, 2022, 36 (02) :507-515
[18]  
DeZern Amy E, 2019, Am Soc Clin Oncol Educ Book, V39, P400, DOI 10.1200/EDBK_239083
[19]   The longitudinal dynamics and natural history of clonal haematopoiesis [J].
Fabre, Margarete A. ;
de Almeida, Jose Guilherme ;
Fiorillo, Edoardo ;
Mitchell, Emily ;
Damaskou, Aristi ;
Rak, Justyna ;
Orru, Valeria ;
Marongiu, Michele ;
Chapman, Michael Spencer ;
Vijayabaskar, M. S. ;
Baxter, Joanna ;
Hardy, Claire ;
Abascal, Federico ;
Williams, Nicholas ;
Nangalia, Jyoti ;
Martincorena, Inigo ;
Campbell, Peter J. ;
McKinney, Eoin F. ;
Cucca, Francesco ;
Gerstung, Moritz ;
Vassiliou, George S. .
NATURE, 2022, 606 (7913) :335-+
[20]   Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers [J].
Feusier, Julie E. ;
Arunachalam, Sasi ;
Tashi, Tsewang ;
Baker, Monika J. ;
VanSant-Webb, Chad ;
Ferdig, Amber ;
Welm, Bryan E. ;
Rodriguez-Flores, Juan L. ;
Ours, Christopher ;
Jorde, Lynn B. ;
Prchal, Josef T. ;
Mason, Clinton C. .
BLOOD CANCER DISCOVERY, 2021, 2 (03) :226-237